Vous êtes ici

FSD Pharma Inc. Subordinate Voting Shares

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
HUGE
Indice CSE: 
Devise: 

FSD Pharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. ("Lucid"), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) ("Lucid-MS"). Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma invented unbuzzd™ and spun it out its OTC version to a company, Celly Nutrition, led by industry veterans. FSD retains ownership of 25.71% (March 31, 2024) of Celly Nutrition Corp. at www.cellynutrition.com. The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd ™ until payments to FSD Pharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Additionally, FSD Pharma retains a large tax loss carry forward of approximately CAD$130 million and could be utilized in the future to offset tax payable obligations against future profits. FSD Pharma retains 100% of the rights to develop similar product or alternative formulations specifically for pharmaceutical / medical uses. FSD Pharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property.

Vous êtes ici

FSD Pharma Inc. Subordinate Voting Shares (HUGE)

SEDAR Information

Information d'entreprise

Addresse
520 William Street
Cobourg, ON K9A 3A5
Canada
Téléphone
(289) 677-0806
Fax
(905) 373-0303
Courriel
[email protected]
URL
http://www.fvpharma.com
Date d’inscription à la cote
Mardi, mai 29, 2018
Agent de transfert
Marrelli Trust Company Limited
Relations avec les investisseurs
Sandra Huard
Courriel
[email protected]
Vérificateur
MNP LLP

Capitalisation

Capitalisation: 
50598607
Réservé à l'émission: 
62774529

Company Officers

Anthony Durkacz, Founder & Executive Co-Chairman
Zeeshan Saeed, Founder & Executive Co-Chairman

Bulletins